Home > Healthcare > Medical Devices > Diagnostic Devices > ovulation testing kits market
Get a free sample of Ovulation Testing Kits Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ovulation Testing Kits Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
A range of factors, including lifestyle changes, stress, and delayed childbearing, has led to an increase in fertility issues among women. For instance, according to the CDC data, in the U.S., approximately 11% of women of childbearing age experience infertility, and about 6% of married women aged 15 to 49 years face infertility. Thus, ovulation testing kits provide a cost-effective and non-invasive means of understanding one's fertility window, helping couples address these challenges and plan for pregnancy effectively.
U.S. ovulation testing kits market accounted for USD 672 million in 2022 and is predicted to witness substantial growth through 2032 primarily due to the region
Swiss Precision Diagnostics GmbH (Clearblue), ClinicalGuard, Wondfo, AccuMed, PREGMATE, iProven, and Wellify (Piramal group), Femometer, Proov, Easy@Home Fertility, Ro, Fairhaven Health, and Prega News (Mankind pharma).
The pharmacies and drugstores segment accounted for over 41% market share in 2022 and will grow through 2032 as these stores offer easy accessibility, provide professional guidance, and a variety of product options.
The global ovulation testing kits indystry was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032.